Implications of the KHDC4-TRAF2 axis in the context of prostate cancer prognosis
Rattachement africain : tw. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
The inability to effectively identify the formation of advanced-stage tumors poses a challenge in precisely determining when to intervene in prostate cancer (PCa). Despite the use of PSA as a screening factor, it still falls short in significantly improving the diagnosis and prognosis of advanced PCa. Identifying novel prognosis biomarkers to assist in confirming the progression of advanced PCa will contribute to more precise and effective therapeutic approaches. Through a comparative analysis between late-stage and early-stage TCGA-PRAD transcriptomes, KHDC4 has been identified as a key and specific member of the KHDC family that shows increased expression in PCa. The elevated levels of KHDC4 in late-stage and lymph node metastasis are positively correlated with poorer overall survival and disease-free survival rates in PCa patients. Simulated molecular regulation networks and in vitro results support the notion that the KHDC4-TRAF2 axis contributes to tumor malignancy features in late-stage and lymph node metastasis tumor samples, consequently correlating with worse progression-free interval and disease-free interval prognosis values in TCGA-PRAD. It is noteworthy that the positive correlation of the distribution of KHDC4 and TRAF2 with the Gleason score is superior to that of KLK3. Promoter analysis reveals that KHDC4 and TRAF2 share a similar upstream regulator, E2F4, for their transactivation. Molecular simulated profiles, mimicking downstream effectors under both KHDC4 and TRAF2 regulation, can be utilized as signatures for overall survival and disease-free survival prognosis purposes. In conclusion, this systematic analysis study indicates that the axis of KHDC4-TRAF2 may serve as a valuable prognostic model for evaluating advanced PCa.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Implications of the KHDC4-TRAF2 axis in the context of prostate cancer prognosis
- Date Crossref
- 23/06/2025
- Éditeur
- Impact Journals, LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Taipei Medical University-Shuang Ho Hospital Department of Urology pays non établi dans la noticeÉtablissement de santé
-
Taipei Medical University pays non établi dans la noticeUniversité ou école supérieure
-
National Yang Ming Chiao Tung University pays non établi dans la noticeUniversité ou école supérieure
-
School of Medicine Department of Urology pays non établi dans la noticeUniversité ou école supérieure
-
College of Medicine Graduate Institute of Clinical Medicine pays non établi dans la noticeUniversité ou école supérieure
-
College of Medical Science and Technology Graduate Institute of Cancer Biology and Drug Discovery pays non établi dans la noticeUniversité ou école supérieure
Department of Urology — Taipei Medical University-Shuang Ho Hospital, Taipei Medical University et National Yang Ming Chiao Tung University, avec 3 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.